Balyasny Asset Management’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,607
Closed -$242K 3288
2025
Q2
$242K Buy
+5,607
New +$216K ﹤0.01% 2541
2025
Q1
Sell
-7,403
Closed -$302K 3130
2024
Q4
$302K Buy
+7,403
New +$308K ﹤0.01% 2384
2024
Q3
Sell
-7,568
Closed -$331K 3018
2024
Q2
$331K Sell
7,568
-21,527
-74% -$1.04M ﹤0.01% 2203
2024
Q1
$1.39M Buy
+29,095
New +$1.31M ﹤0.01% 1663
2021
Q2
Sell
-54,587
Closed -$4.12M 2218
2021
Q1
$4.12M Sell
54,587
-66,448
-55% -$4.84M 0.02% 765
2020
Q4
$9.17M Sell
121,035
-26,468
-18% -$1.72M 0.05% 457
2020
Q3
$7.29M Sell
147,503
-59,113
-29% -$3.34M 0.05% 487
2020
Q2
$10.9M Buy
206,616
+197,541
+2,177% +$9.38M 0.09% 314
2020
Q1
$319K Buy
+9,075
New +$530K ﹤0.01% 986
2019
Q3
Sell
-199,109
Closed -$20.9M 1445
2019
Q2
$20.9M Buy
199,109
+16,024
+9% +$1.61M 0.13% 212
2019
Q1
$19.3M Sell
183,085
-72,737
-28% -$7.31M 0.13% 231
2018
Q4
$21.4M Buy
255,822
+198,901
+349% +$18M 0.15% 187
2018
Q3
$5.8M Buy
+56,921
New +$5.49M 0.03% 651
2018
Q1
Sell
-12,791
Closed -$901K 2199
2017
Q4
$901K Buy
12,791
+7,391
+137% +$533K ﹤0.01% 1364
2017
Q3
$337K Buy
5,400
+1,685
+45% +$99.8K ﹤0.01% 1484
2017
Q2
$213K Buy
+3,715
New +$219K ﹤0.01% 1371
2017
Q1
Sell
-5,200
Closed -$285K 1729
2016
Q4
$285K Buy
+5,200
New +$249K ﹤0.01% 1233

Other funds holding NGVT

Balyasny Asset Management's NGVT Position: Q3 2025 in Review

Balyasny Asset Management sold out of Ingevity (NGVT) in Q3 2025, closing a stake of 5,607 shares — an estimated $242K sold.

Balyasny Asset Management first reported a position in NGVT in Q4 2016 and held it in 17 quarters. The position peaked at $21.4M in Q4 2018. 298 funds tracked by Wall St. Rank hold NGVT as of Q3 2025.

  • Balyasny Asset Management reported no remaining Ingevity position as of Q3 2025 after selling out during the quarter.
  • Balyasny Asset Management sold 5,607 Ingevity shares in Q3 2025, an estimated $242K.
  • Balyasny Asset Management first reported a position in Ingevity in Q4 2016 and held it in 17 quarters.
  • Balyasny Asset Management's Ingevity position peaked at $21.4M in Q4 2018.
  • 298 funds tracked by Wall St. Rank held Ingevity as of Q3 2025.

Based on Balyasny Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.